Life 4 Liam
DL33
Meizon’s small-molecule candidate for NPC. Manufacturing and animal toxicology are the current work, toward a possible Phase 1. It is not in patients.
How it works
DL33 is a small molecule Meizon is developing for NPC. The public update is that GMP manufacturing and animal toxicology were underway, aimed at a possible Phase 1 study.
Until there is a trial in people, there is no dosing, no access program, and no way to know if it will help. It is listed so the name is not a blank.
Who it is for
No one, as a treatment, today. This card is here so families who see the company name know how early the work is.
What it does not do
It does not treat a child yet. It is not in a clinical trial. It is not an approved medicine, and it is not part of the Iowa mRNA program.
What this treatment does
Four short pictures of the idea. Play through, or tap a step. This is a teaching picture, not a medical simulation.
Step 1 of 4 · Where it is
Still before a human study
Meizon’s DL33 is a small-molecule idea for NPC. Families cannot receive it.
Official information
Educational only. Ask an NPC specialist what is right for a specific child or adult. Official sites and FDA pages are the source of prescribing information.